Metabolomics analysis reveals serum biomarkers in patients with diabetic sarcopenia
Authors:
Open Access
- 22 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14
Abstract
Introduction: Diabetic sarcopenia (DS) is characterized by muscle atrophy, slower nerve conduction, reduced maximum tension generated by skeletal muscle contraction, and slower contraction rate. Hence, DS can cause limb movement degeneration, slow movement, reduced balance, reduced metabolic rate, falls, fractures, etc. Moreover, the relevant early biological metabolites and their pathophysiological mechanism have yet to be characterized.Method: The current cross-sectional study employed serum metabolomics analysis to screen potential noninvasive biomarkers in patients with diabetic sarcopenia. A total of 280 diabetic patients were enrolled in the study (n = 39 sarcopenia [DS], n = 241 without sarcopenia [DM]). Ten patients were randomly selected from both groups. Non-targeted metabolomic analysis was performed by ultra-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.Results: A total of 632 differential metabolites were identified, including 82 that were significantly differentially abundant (P < 0.05, VIP > 1, FC > 1.2 or FC < 0.8). Compared with the DM group, the contents of pentadecanoic acid, 5'-methylthioadenosine (5'-MTA), N,N-dimethylarginine (asymmetric dimethylarginine, ADMA), and glutamine in the DS group were significantly increased, while that of isoxanthohumol was decreased.Discussion: Based on receiver operating characteristic curve analysis, pentadecanoic acid, 5'-MTA, ADMA, and glutamine may serve as potential biomarkers of DS. Moreover, ATP-binding cassette (ABC) transporters and the mammalian target of the rapamycin signaling pathway were found to potentially have important regulatory roles in the occurrence and development of DS (P < 0.05). Collectively, the differential metabolites identified in this study provide new insights into the underlying pathophysiology of DS and serve as a basis for therapeutic interventions.Keywords
This publication has 55 references indexed in Scilit:
- The Budget Impact of Oral Nutritional Supplements for Disease Related Malnutrition in Elderly in the Community SettingFrontiers in Pharmacology, 2012
- The Pentose Phosphate Pathway Is a Metabolic Redox Sensor and Regulates Transcription During the Antioxidant ResponseAntioxidants & Redox Signaling, 2011
- Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn StudyClinical Science, 2011
- Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxideAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Medium‐chain fatty acids ameliorate insulin resistance caused by high‐fat diets in ratsDiabetes/Metabolism Research and Reviews, 2009
- Insulin Resistance of Protein Metabolism in Type 2 DiabetesDiabetes, 2008
- l-Arginine, the substrate for NO synthesis: An alternative treatment for premature atherosclerosis?International Journal of Cardiology, 2007
- MethylthioadenosineThe International Journal of Biochemistry & Cell Biology, 2004
- Kidney toxicity of 3‐methylxanthine in the ratJournal of Applied Toxicology, 1984
- Inhibition of lymphocyte transformation by a naturally occurring metabolite: 5′-MethylthioadenosineCellular Immunology, 1980